摘要
近来研究表明,乙型肝炎核心抗体(HBcAb)与肝炎活动程度及药物治疗应答高度相关。本文主要对近年来HBcAb定量水平相关研究进行综述,以期为临床工作提供参考。
Recent studies have shown that hepatitis B core antibody(HBcAb) is highly associated with the degree of he-patitis activity and the response to drug treatment. This article mainly reviews the studies on the quantification of HBcAb in recent years, so as to provide a reference for clinical work in the future.
作者
王亚平
杜忠彩
张凤娟
刘培
牛庆慧
边城
WANG Yaping;DU Zhongcai;ZHANG Fengjuan;LIU Pei;NIU Qinghui;BIAN Cheng(Department of Infectious Diseases,The Affiliated Hospital of Qingdao University,Qingdao 266003,China)
出处
《青岛大学学报（医学版）》
2022年第2期314-316,共3页
Journal of Qingdao University(Medical Sciences)
基金
山东省医药卫生科技发展计划项目(2018WS379)。
